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Abstract
Background: Efforts to monitor malaria transmission increasingly use cross-sectional surveys to estimate transmission
intensity from seroprevalence data using malarial antibodies. To date, seroconversion rates estimated from cross-sectional
surveys have not been compared to rates estimated in prospective cohorts. Our objective was to compare seroconversion
rates estimated in a prospective cohort with those from a cross-sectional survey in a low-transmission population.
Methods and Findings: The analysis included two studies from Haiti: a prospective cohort of 142 children ages #11 years
followed for up to 9 years, and a concurrent cross-sectional survey of 383 individuals ages 0–90 years old. From all
individuals, we analyzed 1,154 blood spot specimens for the malaria antibody MSP-119 using a multiplex bead antigen assay.
We classified individuals as positive for malaria using a cutoff derived from the mean plus 3 standard deviations in antibody
responses from a negative control set of unexposed individuals. We estimated prospective seroconversion rates from the
longitudinal cohort based on 13 incident seroconversions among 646 person-years at risk. We also estimated
seroconversion rates from the cross-sectional survey using a reversible catalytic model fit with maximum likelihood. We
found the two approaches provided consistent results: the seroconversion rate for ages #11 years was 0.020 (0.010, 0.032)
estimated prospectively versus 0.023 (0.001, 0.052) in the cross-sectional survey.
Conclusions: The estimation of seroconversion rates using cross-sectional data is a widespread and generalizable problem
for many infectious diseases that can be measured using antibody titers. The consistency between these two estimates
lends credibility to model-based estimates of malaria seroconversion rates using cross-sectional surveys. This study also
demonstrates the utility of including malaria antibody measures in multiplex assays alongside targets for vaccine coverage
and other neglected tropical diseases, which together could comprise an integrated, large-scale serological surveillance
platform.
Citation: Arnold BF, Priest JW, Hamlin KL, Moss DM, Colford JM Jr, et al. (2014) Serological Measures of Malaria Transmission in Haiti: Comparison of Longitudinal
and Cross-Sectional Methods. PLoS ONE 9(4): e93684. doi:10.1371/journal.pone.0093684
Editor: James M McCaw, University of Melbourne, Australia
Received November 17, 2013; Accepted March 5, 2014; Published April 1, 2014
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: The authors appreciate the financial support of the National Institutes of Health, CDC and the UNDP/World Bank/WHO Special Program for Research
and Training in Tropical Diseases (grants #920528 and #940441). Katy Hamlin was supported by a CDC/APHL Emerging Infectious Disease Fellowship. Besides
the CDC, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Use of trade names is for
identification only and does not imply endorsement by the Public Health Service of by the U.S. Department of Health and Human Services. The findings and
conclusions in this report do not represent the official position of the Centers for Disease Control and Prevention.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: benarnold@berkeley.edu
Introduction
Efforts to monitor malaria transmission to inform control
strategies increasingly use cross-sectional surveys to estimate
transmission intensity from seroprevalence data based on malaria
antibodies [1–8]. The approach has gained popularity because
malaria antibody levels can be measured from dried blood spots
[9], which are relatively easy to collect in the field in cross-
sectional surveys, and this approach to estimating transmission
intensity is far more cost effective and simple compared to
alternative methods such as estimating the entomologic inocula-
tion rate. Another major advantage of the approach compared to
other low-cost methods, such as rapid diagnostic tests, is that the
longevity of antibody responses makes them potentially more
sensitive and informative measure of transmission in low-
transmission environments [2]. A potential disadvantage of using
antibody measures to estimate transmission intensity is that some
antibody responses could saturate at a low transmission intensity,
thus providing less useful information as a monitoring tool as
transmission declines [1]. Nevertheless, serological measures of
malaria infection have been proposed as a preferred diagnostic to
measure community level transmission in the pre-elimination and
elimination phases of malaria control [10].
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e93684
Investigators have estimated malaria transmission intensity from
cross-sectional prevalence surveys using seroconversion rates
estimated with a reversible catalytic model [2]. Previous validation
efforts have shown that the entomological inoculation rate – the
main measure of transmission intensity – is strongly correlated
with seroconversion rates estimated with a model fitted to cross-
sectional data [1,2]. However, to our knowledge, this model-based
approach has not been validated with incident seroconversion
rates measured prospectively in a longitudinal cohort. Given the
increasing use of cross-sectional serological surveys to monitor
malaria transmission, ensuring that model-based seroconversion
rates estimated from cross-sectional surveys are consistent with
rates estimated in prospective cohorts is an important and
necessary step to validate the approach.
The objective of this study was to estimate the malaria
seroconversion rate using antibody measures against merozoite
surface protein-119 (MSP-119) from incident seroconversions
measured in a longitudinal cohort of Haitian children ages 0–11
years old, and compare it to the rate estimated with a reversible
catalytic model fit to a cross-sectional survey of Haitians aged 0–90
years old. Since the longitudinal data provide a direct measure of
the seroconversion rate, a comparison of estimates from the two
approaches provides an important check of the model’s consis-
tency as currently applied in low-transmission settings.
Materials and Methods
Study Population and sample collection
Study populations were set up initially to monitor transmission
of lymphatic filariasis (LF) in a setting of intense LF transmission.
Both longitudinal and cross sectional studies were carried out in
the coastal plain near Léogâne, Haiti, where up to half of the
population was infected with Wuchereria bancrofti [11]. Longitudinal
samples were collected as part of a study of the role of maternal LF
infection on acquisition of LF as previously described [12,13]. A
total of 142 children were enrolled between the ages of 1 month
and 6 years on a rolling basis and followed up at 6–12 month
intervals from 1991–1999 to monitor LF parasitologically and
serologically. Children were followed for up to 9 years and each
child was measured approximately once per year. Finger prick
blood samples were collected from the study children. Additional
details of the cohort have been previously reported [13]. Cross-
sectional blood samples were collected by finger prick in 1998
from 383 individuals in the community of Miton (approximately
5 km from the communities included in the longitudinal study) as
part of an intervention trial to investigate the impact of salt
fortified with diethylcarbamazine on LF [14]. Donor ages ranged
from 2 weeks to 90 years.
Ethics Statement
The protocols for both studies were reviewed and approved by
the Centers for Disease Control and Prevention’s Institutional
Review Board and the Ethical Committee of St. Croix Hospital
(Léogâne, Haiti). After explaining the purpose of the study in
Creole, individuals were asked to provide verbal consent to
participate in the research. The human subjects review boards
approved the verbal consent process due to low literacy rates in the
study communities. In cases of longitudinal follow-up, the study
team documented consent at each study visit. Mothers provided
consent for young children, and children 7 years or older provided
assent. Consent forms included specific permission to share
specimens and to test the samples for other infectious diseases.
Malaria antibody measurement and determination of
seroconversion events
A recombinant GST/MSP-119 fusion protein cloned from P.
falciparum isolate 3D7 (kindly provided by C.W. Kauth and H.
Bujard, Heidelberg University, Germany) was coupled to
SeroMap beads (Luminex Corp., Austin, TX) in phosphate-
buffered saline (pH 7.2) as previously described [13,15]. A total of
120 mg protein was coupled to 12.56106 beads. The MSP-119
assay was included as part of a 28-plex panel for the longitudinal
survey [13] and as part of a 16-plex panel for the cross-sectional
survey. Multiplex assays were conducted using sera diluted in a
polyvinyl alcohol- and polyvinylpyrrolidone-containing buffer
(1:400) and the biotinylated monoclonal anti-IgG and IgG4
antibodies previously described [13]. Data were reported as the
average median fluorescent intensity minus background (MFI-bg)
for the duplicate wells. The magnitude of the fluorescent response
(reported in MFI – bg units) is proportional to the amount of
antigen-specific IgG antibody present in the sample.
We used adult US citizens with no history of foreign travel as an
unexposed population for antibody cutoff values to classify
individuals as seropositive. The mean +3*SD for the MSP-119
antibody response was calculated from the logged values of the
negative control antibody responses. Because samples from the
longitudinal study and the cross-sectional study were run with two
different bead lots, two different cutoff values were used: a cutoff of
365 MFI-bg units was calculated from 63 negative control sera for
the longitudinal study bead set, and a cutoff of 477 MFI-bg units
was calculated from 70 negative control samples for the cross-
sectional study bead set.
Four children ,6 months in the longitudinal cohort and one
child age 2 months in the cross-sectional study had evidence of
maternal antibodies to multiple antigens (including malaria) in the
multiplex panel; we classified them as seronegative in their first
year of life for the analysis. For children who were classified as
seropositive during follow-up we plotted their antibody responses
to identify those who were incident cases versus those who were
positive at their first visit.
Statistical methods
Estimation of seroconversion rates with longitudinal
data. We estimated age-specific seroprevalence in the longitu-
dinal cohort by combining measurements into one-year to three-
year age groups that included enough measurements to estimate
each prevalence with reasonable precision. We also estimated the
seroconversion and seroreversion rates using incident conversions
and reversions divided by the person time at risk over follow-up
[16]. Person time at risk for seroconversion was estimated by
summing the person time for periods where children were
seronegative at the beginning of the period. We estimated the
seroreversion rate in an analogous fashion, but used periods where
children began the period as seropositive. To estimate variability
of the prevalence and rate estimates, we bootstrapped the dataset
with 10,000 replications, resampling children with replacement,
and used the 2.5 and 97.5 percentiles of the bootstrapped sampling
distribution to construct 95% confidence intervals.
With short periods between measurements such as days, the
approach to estimating the rates directly is unbiased [17], but for
longer periods between measurements similar to those used in this
study (typically one year) there is some concern that this approach
could under-estimate the seroconversion rate; the rationale is that
it is possible for a child to become infected and recover between
measurements, and those cases would not be detected by the
surveillance [16]. For this reason, previous longitudinal studies
with measurements separated by weeks or months have also
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estimated malaria incidence and recovery rates using a reversible
catalytic model that attempts to account for the possibility of
multiple infections [16,18]. Since the antibody response to
malarial antigens can last for years in the presence of single- or
multiple infections [19], we would expect seroconversion rates
estimated from incident cases and from a catalytic model to
coincide; we compared the two approaches as an internal validity
check. Text S1 Statistical Details includes details of the reversible
catalytic model used in the analysis. All analyses were conducted
using R version 2.15.2 (www.R-project.org).
Estimation of seroconversion rates with cross-sectional
data. With cross-sectional data, direct information about
seroconversion and seroreversion is unknown since the same
individual is not observed at two points in time. Instead, there is
only current status information for an individual at one point in
time when they are a particular age. The reversible catalytic model
for incidence data can be fit to prevalence data with a
simplification where exposure time is measured by age in years
[1,2]. As with the longitudinal version of the model, the model
parameters estimate seroconversion and seroreversion rates. Text
S1 Statistical Details includes model details. We fit the age-specific
seroconversion model to the cross-sectional dataset using all
individuals aged 0–90 years old, and separately for individuals ages




Among the 142 children enrolled in the longitudinal study in
Leogane, each child was followed for an average of 5.1 years
(range = 0.5, 9.1). The study included 771 total antibody
measurements, and the average number of measurements per
child was 5.4 (range = 2, 9). The 383 individuals enrolled in the
cross-sectional survey in Miton ranged in age from two weeks to 90
years old. Antibody response increased with age in both samples
(Figure 1).
Seroprevalence estimates
Table 1 summarizes the seroprevalence measured in the
longitudinal cohort. Seroprevalence increased in the first years of
life, from 5% among children ,2 years old to 17% for children 6–
8 years old. Table 2 summarizes seroprevalence in the cross-
sectional study for different age categories, which showed a similar
increase in seroprevalence that plateaued by age 20 at over 50%.
The seroprevalence estimates for children #11 years old were
comparable in the two samples (11% 95% CI: [7%, 16%] in the
longitudinal study v. 14% [9%, 20%] in the cross-sectional study).
Figure 1. MSP-119 antibody optical density responses for different age categories. Panel A includes antibody responses from the
longitudinal study in Léogâne, Haiti, 1991–1999. Panel B includes antibody responses from the cross-sectional survey in Miton, Haiti, 1998.
doi:10.1371/journal.pone.0093684.g001
Table 1. Age-specific seroprevalence estimates based on the
MSP-119 antibody measured in 142 children followed
longitudinally in Léogâne, Haiti 1991–1999.
Age Category (years)
Median Age
(years) N % 95% CI
[0–2) 1.0 127 5 (1, 9)
[2–3) 2.5 98 7 (2, 14)
[3–4) 3.5 114 10 (4, 16)
[4–5) 4.6 103 15 (7, 23)
[5–6) 5.4 115 12 (6, 20)
[6–8) 6.8 125 17 (8, 26)
[8–11.9] 9.1 89 12 (3, 24)
All ages [0–11.9] 4.5 771 11 (7, 16)
N is number of measurements.
CI: Confidence Interval.
doi:10.1371/journal.pone.0093684.t001
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Seroconversion rate estimates
In the longitudinal study, 25 children were identified as
seropositive for malaria during follow-up. Of these, 13 were
incident seroconversions and 12 had seroconverted by their first
measurement (Figure 2). No children showed a pattern of multiple
infections based on their MSP-119 antibody levels. Over the 9
years of follow-up, there were 558 periods where children began
periods as seronegative corresponding to 646.185 person years;
there were 71 periods where children began periods as seropositive
corresponding to 71.844 person years. There were 13 incident
seroconversions (rate = 0.020 per year) and 11 incident serorever-
sions (rate = 0.153 per year).
Table 3 compares seroconversion and seroreversion rate
estimates from the longitudinal study with those from the cross-
sectional study. Seroconversion rates estimated among children
ages #11 years were highly comparable using the two approaches
(seroconversion rate estimated from incidence data = 0.020
[0.010, 0.032]; estimated from cross-sectional data = 0.023
[0.001, 0.052]; Table 3). The seroconversion rate estimated with
the model across all ages in the cross-sectional sample was 0.039
(0.027, 0.052), and the model provided a reasonable fit to the
seroprevalence data (Figure 3). The seroreversion rate could not be
estimated accurately with either approach due to the small
number of individuals in the studies who were seropositive.
Discussion
In this analysis of two separate studies from Haiti we found that
the seroconversion rate for the MSP-119 malaria antibody was
very similar when estimated from incident seroconversions in a
longitudinal cohort and from a model fit to cross-sectional
seroprevalence data. This finding is important because it provides
a direct validation of the use of cross-sectional malaria seroprev-
alence data to estimate seroconversion rates in low-transmission
settings. Earlier analyses demonstrated that the seroconversion
rate measured from cross-sectional surveys was strongly associated
with the entomological inoculation rate [1,2]; our finding of
concordance of seroconversion rates estimated from separate
longitudinal and cross-sectional studies in the same low-transmis-
sion region lends further credibility to this approach, and
underscores its potential utility in large-scale, cross-sectional
surveillance activities.
The estimation of seroconversion rates using cross-sectional
data is a widespread and generalizable problem for many
infectious diseases. Although the model used to estimate malaria
seroconversion rates from cross-sectional surveys is an extreme
simplification of a complex immunological process, numerous field
studies including the present study have found that the model fits
the data well [1–8]. Simple, parsimonious models such as the one
used in this analysis should be favored over more complex models
as long as the simple approach provides a reasonable approxima-
tion to the observed data [20]. A series of recent studies have
added one layer of model complexity to allow for multiple
seroconversion rates to be estimated for different age groups [3,5–
7]. A motivation for estimating separate rates in different age
groups is to allow for changes in transmission due to intervention.
In the present study, there was no well-defined intervention that
would have abruptly changed transmission, and a single serocon-
version rate over all ages provided a good fit to the seroprevalence
data (Figure 3). Nevertheless, the seroconversion rate estimated for
children ages 0–11 years was lower than the rate estimated using
data from all ages in the cross-sectional survey, suggesting
potentially reduced transmission in the younger cohort. Text S1
Statistical Details includes model results from the cross-sectional
survey that allowed for two seroconversion rates with an age
breakpoint chosen to maximize the overall likelihood [3];
consistent with the primary analysis, the more complex model
estimated a lower seroconversion rate among younger individuals
compared to older individuals, which is consistent with a secular
trend of reduced transmission in this population. Based on these
data, it would appear that transmission of malaria in Haiti is
relatively low and, at least anecdotally, it appears that transmission
has either declined in recent years or is less intense at younger
ages. Potential explanations for a secular decline are not clear as
there were no systematic control activities during the time period
when samples were collected. Importantly, we found no evidence
for antibody saturation using MSP-119, which underscores its
utility as a sensitive surveillance tool in low-transmission settings.
More recently, Bretscher et al. [21] used a different approach
based on a Bayesian Hidden Markov Model to estimate
seroconversion and reversion rates from a longitudinal cohort in
Indonesia. Rather than classify individual children as seropositive
or negative at each point in time, as we did in the present analysis,
the approach assigns a probability to each measurement of the
likelihood that the individual is infected. The rationale that
Bretscher et al. used to justify using a more complex Hidden
Markov Model is twofold: (i) individual seroconversion events are
lost when converting continuous antibody measurements to
prevalence in different age groups, and (ii) that antibody levels
are inherently noisy and imposing a fixed cutoff may lead to false
conversion and reversion events.
Our results suggest that the simpler calculation of seroconver-
sion rates directly from incident seroconversions is a viable
alternative to a more complex, Hidden Markov Model approach.
First, as we have demonstrated there is no need to collapse
individual information into age categories and group level
seroprevalence to estimate seroconversion rates with longitudinal
data – rates can be estimated directly from incident seroconver-
sions [16–18]. However, the issue of antibody variability around a
fixed cutoff value is a valid concern. In the present study, the
majority of seropositive antibody measures were far beyond the
threshold but there were instances where antibody levels oscillated
around the cutoff value (e.g., IDs 3132, 4607, 4703; Figure 2). We
used individual antibody profile plots (Figure 2) and scientific
judgment to rule out non-incident conversions in the rate
calculations. This was feasible for a study with 25 seropositive
Table 2. Age-specific seroprevalence estimates based on the




(years) N % 95% CI
[0–5) 2 51 6 (1, 16)
[5–10) 7 67 13 (6, 24)
[10–15) 12 82 34 (24, 45)
[15–20) 16 43 49 (33, 65)
[20–30) 24 51 57 (42, 71)
[30–40) 33 32 53 (35, 71)
[40–90] 50 57 54 (41, 68)
All ages [0–90] 14 383 36 (31, 41)
Ages [0–11] 7 157 14 (9, 20)
N is number of individuals.
CI: Confidence Interval.
doi:10.1371/journal.pone.0093684.t002
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children and 13 incident seroconversions and would be a
reasonable approach for similarly sized studies (e.g., Bretscher et
al. observed just 3 incident seroconversions in their study [21]). In
a study with a very large number of seroconversions then it should
be possible to develop a simple algorithmic approach that
identifies incident seroconversions for a given antibody based on
a defined period spent seronegative before the conversion. Future
studies could also consider the use of quantitative antibody
responses to measure malaria transmission. The use of quantitative
antibody responses would avoid the problem of choosing a cutoff
for classifying seropositive samples and would potentially retain
more information in the analysis. The methods required to
estimate malaria transmission intensity from quantitative antibody
responses is a potential area for future research.
Serum samples from these communities were tested by multiplex
as part of a study of risk factors for acquisition of LF; MSP-119 was
included in the multiplex, along with antigens from enteric pathogens
and vaccine-preventable diseases to better understand the public
health context in these communities and the potential interactions
between LF and other infections. The current results illustrate the
potential of this approach to capture seroincidence data for infections
beyond those that were the initial focus of the study. Less clear at this
point is the extent to which reversible catalytic models might be
successfully applied to the other infections we monitored. These
efforts are the focus on ongoing efforts in our labs. Independent of
whether or not reversible catalytic models can be applied generally as
measures of transmission intensity, multiplex serologic assays
represent a powerful tool for capturing useful public health data
with simple, dried blood spot surveys.
A limitation of the analysis was that only 25 children were classified
as seropositive in the longitudinal study, which meant that it was
impossible to estimate age-specific seroconversion rates and it was
also impossible to estimate the seroreversion rate with precision. The
wide confidence intervals and variation in point estimates for the
seroreversion rate in analyses limited to children #11 years reflect the
lack of information needed to accurately estimate that parameter
(Table 3). Although the estimate of the seroreversion rate from the
catalytic conversion model fit to cross-sectional data over all ages was
more precise, we expect imprecise estimation of seroreversion rates to
be a common problem for studies in low-transmission settings
because of the relatively low prevalence of infection – this limitation
was pointed out in an early description of the approach [2]. However,
if the main parameter of interest is the seroconversion rate, then this
study suggests that it can be estimated with reasonable precision
Figure 2. MSP-119 antibody optical density profiles for children in the Léogâne, Haiti longitudinal study, 1991–1999. Panel A includes
individuals with incident seroconversions, and panel B includes those who were seropositive at their first measurement. The dashed line marks the
cutoff value (365) used to determine seropositive antibody levels. The light grey lines plot antibody profiles for seronegative children, and the solid
black line in each plot is a loess smoother over the seronegative children antibody levels.
doi:10.1371/journal.pone.0093684.g002
Figure 3. Seroprevalence estimates from the cross-sectional survey in Miton, Haiti, 1998. Seroprevalence estimates for the age categories
in Table 2 (points) are plotted at the midpoint of the age categories, and the line in the plot is the predicted prevalence from the reversible catalytic
model.
doi:10.1371/journal.pone.0093684.g003
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despite limited information about seroreversion. Even if a study’s
main focus is mainly the seroconversion rate, estimating differences in
that rate – either by age, over time, or between groups – requires that
the study collect sufficient observations in each group to accurately
estimate separate rates.
These studies were not designed to follow malaria specifically and
we have no parasitologic data that would confirm that children
were, in fact, malaria infected. That limitation notwithstanding, not
all malaria infections may manifest as patent parasitemia, so
serological measures of infection may be a more accurate
representation of the true level of transmission in the population –
particularly in areas of low transmission [2]. It is also important to
point out that the longitudinal and cross-sectional specimens were
not collected from the same community; however, these commu-
nities are located with 5 km of each other and are similar in terms of
ethnicity, genetic heritage, house structures, local environments and
socioeconomic status. Although MSP-119 antibody responses are
considered to be sensitive and specific measures of malaria infection,
use of multiple malaria antigens would improve the sensitivity of
case detection. We estimate that use of a single antigen would
capture at least 75% of incident infections (Priest et al., unpublished
observations), so our estimates of infection prevalence should be
reasonably accurate. Inclusion of additional malaria antigens in
future studies, a straightforward approach with the multiplex, will
add to the value of these analyses.
Conclusion
Our finding of close agreement between malaria seroconversion
rates estimated in a prospective cohort study with those estimated
using a reversible catalytic model fit to cross-sectional prevalence
data lends additional credibility to the use of cross-sectional,
serological surveys to monitor malaria transmission in low-
transmission settings. These results demonstrate the utility of
including malaria antibody measures in multiplex assays alongside
targets for vaccine coverage and other neglected tropical diseases,
which together could comprise an integrated, large-scale surveil-
lance platform.
Supporting Information
Text S1 Statistical Details. This supporting information
includes details about the statistical models used in the analysis
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